Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × Withdrawn × Hypothyroidism × Clear all

Phase

Phase NA 1 Phase 2/3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Colorectal Neoplasms 6 Carcinoma, Hepatocellular 5 Head and Neck Neoplasms 4 Breast Neoplasms 4 Squamous Cell Carcinoma of Head and Neck 2 Pancreatic Neoplasms 2 Neoplasms, Squamous Cell 2 Glioblastoma 2 Colonic Neoplasms 2 Urinary Incontinence 1 Tuberous Sclerosis 1 Sarcoma 1 Recurrent respiratory papillomatosis 1 Recurrence 1 Rectal Neoplasms 1 Prostatic Neoplasms 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Precancerous Conditions 1 Postoperative Complications 1 Papillomavirus Infections 1 Papilloma 1 Ovarian Neoplasms 1 Orgasm 1 Oligodendroglioma 1 Neoplasms 1 Neoplasm Metastasis 1 Myasthenia Gravis 1 Melanoma 1 Medication Adherence 1 Lymphoma, T-Cell, Peripheral 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02548715 2022-07-13

LSHT

University of Alberta

Phase 2/3 Withdrawn

Hypothyroidism, Neoplasms, Postoperative Complications

Data powered by HemOnc (CC BY 4.0) Colophon ⚡